Patent ID: 7018633

Claim:
A method for treating a human immunodeficiency virus infection comprising administering an effective amount of a composition comprising: a member selected from the group consisting of: (i) a compound represented by the formula (T m -A-X-B)-H n or (A-X-B-T m )-H n , wherein A is a protein synthesis inactivating toxin that is inactive until X is digested; X is a peptide susceptible to digestion by a human immunodeficiency virus protease; B is a lectin or a segment thereof, T is a targeting moiety, H is a hydrophobic agent, m is 0 or an integer of at least 1, and n is an integer of at least 1, (ii) a compound having a hydrophobic agent and further represented by the formula N-X-A or A-X-N, wherein A is a protein synthesis inactivating protein that is inactive until X is digested, X is a peptide susceptible to digestion by a human immunodeficiency virus protease, and N is an adenine moiety or functional equivalent thereof, and (iii) mixtures of (i) and (ii); and a pharmaceutically acceptable carrier.